4.4 Review

DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer

Journal

ONCOLOGY LETTERS
Volume 22, Issue 6, Pages -

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2021.13111

Keywords

doublecortin-like kinase protein 1; colorectal cancer; tuft cells; stem cell niche; cancer-initiating cells

Categories

Ask authors/readers for more resources

DCLK1 is a microtubule-associated protein with roles in early neurogenesis and the gastrointestinal tract, as well as implications in various types of cancer. Its underlying molecular mechanisms remain unclear, but potential therapeutic strategies targeting cancer cells are being explored through understanding its interactions with similar proteins.
Doublecortin-like kinase protein 1 (DCLK1) is a microtubule-associated protein with a C-terminal serine/threonine kinase domain. Its expression was first reported in radial glial cells, where it serves an essential role in early neurogenesis, and since then, other functions of the DCLK1 protein have also been identified. Initially considered to be a marker of quiescent gastrointestinal and pancreatic stem cells, DCLK1 has recently been identified in the gastrointestinal tract as a marker of tuft cells. It has also been implicated in different types of cancer, where it regulates several vital pathways, such as Kras signaling. However, its underlying molecular mechanisms remain unclear. The present review discusses the different roles of DCLK1 and its interactions with other proteins that are homologically similar to DCLK1 to develop a novel therapeutic strategy to target cancer cells more accurately.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available